Evidence map›Paper›PMID 42587336›Full record

ArticleResearch integrity and peer review2026

Follow-up investigation of ethics approvals and regulatory compliance in publications from the IHU-Mi.

Fabrice Frank, Elisabeth M Bik, Gideon Meyerowitz-Katz, Jérôme Barriere, Éric Billy, Véronique Saada, Alexander Samuel, Jacques Robert, Lonni Besançon

Abstract read
In one paragraph

Article in Research integrity and peer review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fabrice FrankIndependant Researcher, Essaouira, Marocco.
Elisabeth M BikHarbers Bik LLC, San Francisco, USA.
Gideon Meyerowitz-KatzUniversity of Wollongong, Wollongong, Australia.
Jérôme BarriereMedical Oncology Department, Polyclinique Saint-Jean, Cagnes-Sur-Mer, France.
Éric BillyIndependant Researcher, Strasbourg, France.
Véronique SaadaBiopathology department, Gustave Roussy Anti-Cancer Center, Villejuif, France.
Alexander SamuelIndependant Researcher, Nice, France.
Jacques RobertINSERM Unité 1312, University of Bordeaux, Bordeaux, France.
Lonni BesançonLinköping University, Linköping, Sweden. lonni.besancon@liu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFollowing our previous investigation of 456 articles published by the IHU-Méditerranée Infection (IHU-Mi) institute in Marseille, France, subsequent editorial actions, institutional reviews, and reports from French authorities provided additional evidence relevant to our concerns. We therefore extended our investigation to the broader IHU-Mi bibliography to assess potential breaches of the Declaration of Helsinki, French regulations governing research involving human participants, and the consistency between reported studies and the ethics approvals cited.

methodsWe assessed 2,674 IHU-MI publications identified through PubMed, Google Scholar, PubPeer, and manual searches. We excluded articles not reporting research involving human participants, articles clearly reporting retrospective studies without ethics flaw, and articles for which editorial investigations had clarified our concerns. We compared the remaining articles with the relevant French legal framework and, where available, with ethics approvals obtained through public transparency procedures or other sources.

resultsWe identified ethical or legal concerns in 853 articles from this institute. These included at least 75 articles with retrospective approvals, 194 describing research conducted abroad without mention of local approvals, 343 not mentioning ethics approval, and 426 describing sample collection from healthy volunteers with concerns. Among 374 articles for which we obtained the cited ethics approval documents, at least 304, or 81.3%, described sample collections that were not covered by the corresponding approval. Since our previous investigation, editorial and institutional responses have led to 64 retractions and 270 expressions of concern, and have clarified or substantiated many of the concerns raised. We also found that the local ethics committee issuing most of the approvals may not have been sufficiently independent from the authors.

conclusionInstitutional reports and editorial decisions have substantiated many of the concerns identified in our analysis, although a small subset of cases was attributable to unintentional errors. Our findings indicate widespread and longstanding problems in research ethics compliance within the IHU-Mi bibliography and support the need for continued editorial and institutional review.

Identifiers

PMID42587336
PMCPMC13465284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.